SLDLR IN VIRAL HEPATITIS
1 Assignment
0 Petitions
Accused Products
Abstract
The invention relates to the use of the souluble LDL receptor (sLDLR) in viral hepatitis.
3 Citations
39 Claims
-
1-20. -20. (canceled)
- 21. A method for treating and/or preventing liver infection, comprising administering an effective inhibiting amount of sLDLR to a patient in need thereof to treat and/or prevent liver infection.
-
37. A method for treating and/or preventing liver infection, comprising administering to a patient in need thereof an expression vector comprising the coding sequence of an sLDLR to treat and/or prevent liver infection.
-
38. A method for treating and/or preventing liver infection, comprising administering to a patient in need thereof a vector for inducing and/or enhancing the endogenous production of an sLDLR in a cell to treat and/or prevent liver infection.
-
39. A method for treating and/or preventing liver infection, comprising administering to a patient in need thereof a cell that has been genetically modified to produce an sLDLR to treat and/or prevent liver infection.
Specification